tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Balance Sheet

Compare
919 Followers

Immunovant Balance Sheet

Immunovant's total assets for Q2 2026 were $582.96M, a decrease of -11.87% from the previous quarter. IMVT total liabilities were $63.25M for the fiscal quarter, a 19.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 776.22M$ 666.71M$ 405.84M$ 515.56M$ 412.49M
Total Liabilities
$ 68.78M$ 48.95M$ 43.34M$ 45.74M$ 21.01M
Total Equity Gross Minority
$ 707.45M$ 617.76M$ 362.49M$ 469.82M$ 391.48M
Other Metrics
Currency in USD

Immunovant Debt to Assets